Trial underway to study safety of retinal gene therapy for dry AMD

• Posted on: Feb 26 2019
• By: Saratoga Opthalmology
• Leave a response

Last week, an 80-year-old Oxford woman became the first person to receive an experimental retinal gene therapy for dry AMD.
Source: AAO

Posted in: Uncategorized